I
0.377
-0.02 (-3.95%)
| Previous Close | 0.392 |
| Open | 0.372 |
| Volume | 530,595 |
| Avg. Volume (3M) | 7,939,059 |
| Market Cap | 17,230,560 |
| Price / Sales | 0.680 |
| Price / Book | 0.860 |
| 52 Weeks Range | |
| Earnings Date | 28 Mar 2025 |
| Profit Margin | -115.93% |
| Operating Margin (TTM) | -46.38% |
| Diluted EPS (TTM) | -0.750 |
| Quarterly Revenue Growth (YOY) | -0.40% |
| Total Debt/Equity (MRQ) | 50.26% |
| Current Ratio (MRQ) | 1.01 |
| Operating Cash Flow (TTM) | -7.74 M |
| Levered Free Cash Flow (TTM) | -2.71 M |
| Return on Assets (TTM) | -13.68% |
| Return on Equity (TTM) | -65.88% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | ImmunoPrecise Antibodies Ltd. | Bearish | Bearish |
AIStockmoo Score
0.0
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | 0.00 |
|
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 5.27% |
| % Held by Institutions | 4.17% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Gradient Capital Advisors, Llc | 31 Dec 2024 | 26,808 |
| 52 Weeks Range | ||
| Median | 5.00 (1,228.02%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 31 Mar 2025 | 5.00 (1,228.02%) | Buy | 0.365 |
| 14 Mar 2025 | 7.00 (1,759.23%) | Buy | 0.385 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |